Sun Pharma gets boost with US FDA approval for Gleevec

Sun Pharmaceutical announced it received approval from the US FDA for generic copies of Gleevec, a drug that treats chronic myeloid leukemia.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news